Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

Endocrinology and Diabetology

585 posts
  • This content is machine translated Venous thromboembolism

Risks associated with hormone therapy

Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism…
CME-Test
View Post
  • 5 min
  • This content is machine translated Diabetic nephropathy

SGLT-2 inhibitor protects heart and kidney also in the real-world setting

Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular and renal diseases [1, 2]. However, SGLT-2 inhibitors not only lower blood glucose levels but also have cardio- and…
View Post
  • 7 min
  • This content is machine translated Testosterone

Testosterone substitution in the older man: for whom, when and how?

Hypogonadism is a clinical syndrome in which dysfunction in the hypothalamic-pituitary-gonadal axis results in decreased production of testosterone with clinical symptoms of testosterone deficiency. When should substitution take place?
View Post
  • 4 min
  • This content is machine translated Diabetes Cases

Intensification of the treatment of type 2 diabetes mellitus

In a 63-year-old patient, although glucose metabolic control is quite good, there is still potential for optimizing diabetes management. Thus, with a change in therapy, his pre-existing cardiovascular conditions can…
View Post
  • 4 min
  • This content is machine translated SGLT-2 inhibitors and GLP-1-RA

How they can protect against diabetic sequelae

In recent years, numerous new glucose-lowering agents have been developed. SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular and nephroprotective effects in large clinical endpoint studies. The variety of…
View Post
  • 3 min
  • This content is machine translated Diabetes Cases

Type 2 diabetes mellitus and advanced renal failure

A 73-year-old female patient who has had type 2 diabetes mellitus for 10 years is unhappy with her weight and needs improved glycemic control. However, macronutrient malnutrition combined with advanced…
View Post
  • 2 min
  • This content is machine translated Hypertension

Detect changes already in childhood and initiate prevention

High blood pressure is the cause of a number of sequelae, such as microvascular retinal changes. Hypertension can already begin in childhood – in most cases undetected. This is to…
View Post
  • 6 min
  • This content is machine translated Diabetes treatment

Insulin therapy in type 2 diabetics: an update.

The most modern representatives of basal insulins are ultra-long acting and associated with low hypoglycemia rates. Mixed insulin or combination preparations of GLP-1-RA and a long-acting insulin are good alternatives…
View Post
  • 2 min
  • This content is machine translated Heart failure

SGLT2 inhibitors improve cardiovascular risk

SGLT2 inhibitors are used with great success as antidiabetic agents. However, new study data revealed a positive side effect: the drug group appears to have additional cardioprotective as well as…
View Post
  • 5 min
  • This content is machine translated From symptom to diagnosis

Spondylosis hyperostotica – common vertebral change in the elderly.

Spondylosis hyperostotica is the most common non-inflammatory disease of the spine, with an age-correlated increase in prevalence. This degenerative spinal disease occurs more frequently in patients with diabetes mellitus and…
View Post
  • 4 min
  • This content is machine translated Diabetes treatment

Additive glucose-lowering therapy for type 1 diabetics – weighing benefits and risks

Overweight type 1 diabetics in whom insulin therapy alone is not sufficient for glycemic control may receive additional oral treatment with the SGLT2 inhibitor dapagliflozin or the dual SGLT1/SGLT2 inhibitor…

Posts pagination

Previous 1 … 34 35 36 37 38 … 54 Next
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.